Aberrant P-cadherin expression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter methylation status

被引：0
|
作者：
Albergaria, A
Paredes, J
Oliveira, J
Ricardo, S
Leitao, D
Milanezi, F
Schmitt, F
Jerónimo, C
机构：
[1] Univ Porto, IPATIMUP, Lab Mammary Pathol, P-4100 Oporto, Portugal
[2] IPO, Dept Genet, Oporto, Portugal
[3] Univ Fernando Pessoa, Sch Hlth Sci, Oporto, Portugal
[4] Univ Porto, Fac Med, P-4100 Oporto, Portugal
[5] Univ Minho, Sch Hlth Sci, Oporto, Portugal
来源：
FEBS JOURNAL | 2005年 / 272卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：474 / 474
页数：1
相关论文
共 30 条
  • [1] P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation
    Paredes, J
    Albergaria, A
    Oliveira, JT
    Jerónimo, C
    Milanezi, F
    Schmitt, FC
    CLINICAL CANCER RESEARCH, 2005, 11 (16) : 5869 - 5877
  • [2] CDH3 promoter hypomethylation and P-cadherin expression in invasive breast carcinoma
    Carol Lovegrove
    Nature Clinical Practice Oncology, 2005, 2 (11): : 542 - 543
  • [3] Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas
    Ana Catarina Figueira
    Catarina Gomes
    Joana Tavares de Oliveira
    Hugo Vilhena
    Júlio Carvalheira
    Augusto JF de Matos
    Patrícia Dias Pereira
    Fátima Gärtner
    BMC Veterinary Research, 10
  • [4] Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas
    Figueira, Ana Catarina
    Gomes, Catarina
    de Oliveira, Joana Tavares
    Vilhena, Hugo
    Carvalheira, Julio
    de Matos, Augusto J. F.
    Pereira, Patricia Dias
    Gaertner, Fatima
    BMC VETERINARY RESEARCH, 2014, 10
  • [5] CDH3/P-cadherin overexpression in breast carcinomas: its regulatory mechanisms, the role in cell invasion, and the association with cancer stem cell properties
    Joana Paredes
    BMC Proceedings, 4 (Suppl 2)
  • [6] P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas
    Lo Muzio, L
    Pannone, G
    Mignogna, MD
    Staibano, S
    Mariggiò, MA
    Rubini, C
    Procaccini, M
    Dolci, M
    Bufo, P
    De Rosa, G
    Piattelli, A
    HISTOLOGY AND HISTOPATHOLOGY, 2004, 19 (04) : 1089 - 1099
  • [7] Aberrant P-cadherin expression: Is it associated with estrogen-independent growth in breast cancer?
    Paredes, J
    Milanezi, F
    Reis, JS
    Leitao, D
    Athanazio, D
    Schmitt, F
    PATHOLOGY RESEARCH AND PRACTICE, 2002, 198 (12) : 795 - 801
  • [8] Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas
    Toyooka, KO
    Toyooka, S
    Virmani, AK
    Sathyanarayana, UG
    Euhus, DM
    Gilcrease, M
    Minna, JD
    Gazdar, AF
    CANCER RESEARCH, 2001, 61 (11) : 4556 - 4560
  • [9] CCAAT/Enhancer Binding Protein β (C/EBPβ) Isoforms as Transcriptional Regulators of the Pro-Invasive CDH3/P-Cadherin Gene in Human Breast Cancer Cells
    Albergaria, Andre
    Resende, Carlos
    Nobre, Ana Rita
    Ribeiro, Ana Sofia
    Sousa, Barbara
    Machado, Jose Carlos
    Seruca, Raquel
    Paredes, Joana
    Schmitt, Fernando
    PLOS ONE, 2013, 8 (02):
  • [10] 3D Chromatin Architecture Re-Wiring at the CDH3/CDH1 Loci Contributes to E-Cadherin to P-Cadherin Expression Switch in Gastric Cancer
    Jose, Celina Sao
    Pereira, Carla
    Ferreira, Marta
    Andre, Ana
    Osorio, Hugo
    Gullo, Irene
    Carneiro, Fatima
    Oliveira, Carla
    BIOLOGY-BASEL, 2023, 12 (06):
123